Gabelli Securities »

Cytokinetics shares owned by Gabelli Securities

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Gabelli Securities from 13F filings

Historical chart of Gabelli Securities investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Gabelli Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Gabelli Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.1M 38k 54.96

More positions owned by Gabelli Securities

Kellanova Equity (K)
Verona Pharma Plc - Depository Recei (VRNA)
Frontier Communications Pare Equity (FYBR)
Cyberark Software Ltd/israel Equity (CYBR)
Chart Industries Equity (GTLS)
Spirit Aerosystems Hold-cl A Equity (SPR)
Gabelli Dividend & Income Tr Exchange Traded (GDV)
Txnm Energy Equity (TXNM)
Allete Equity (ALE)
Gdl Fund Exchange Traded (GDL)
Fox Corp - Class B Equity (FOX)
Wns Holdings Equity (WNS)
Informatica Inc - Class A Equity (INFA)
Liberty Broad C Equity (LBRDK)
Air Lease Corp Equity (AL)

View all positions for Gabelli Securities

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
Tudor Investment Corporation
State Street Corporation
Deep Track Capital
Geode Capital Management
Polar Capital Holdings
Rtw Investments
Susquehanna International
Integral Health Asset Management
Armistice Capital
UBS Group

View all funds holding Cytokinetics